Long-term outcomes in elderly patients with resectable large hepatocellular carcinoma undergoing hepatectomy.

[1]  D. Nagorney,et al.  Surgical Treatment of Hepatocellular Carcinoma , 2017, Cancer control : journal of the Moffitt Cancer Center.

[2]  D. Watters,et al.  Systematic review and meta-analysis of hepatic resection versus transarterial chemoembolization for solitary large hepatocellular carcinoma. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[3]  H. Ohdan,et al.  Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more , 2017, Journal of hepato-biliary-pancreatic sciences.

[4]  Yi-jun Zhao,et al.  A retrospective analysis of long term outcomes in patients undergoing hepatic resection for large (>5 cm) hepatocellular carcinoma , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[5]  S. Hussain,et al.  A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma , 2016, Annals of surgery.

[6]  T. Pawlik,et al.  Hepatocellular carcinoma: From diagnosis to treatment. , 2016, Surgical oncology.

[7]  Chia-Yang Hsu,et al.  Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy , 2016, PloS one.

[8]  V. Mazzaferro,et al.  Effect of age on survival in patients undergoing resection of hepatocellular carcinoma , 2016, The British journal of surgery.

[9]  M. L. de la Mata,et al.  Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  Lei Zhang,et al.  Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis , 2015, Journal of Gastrointestinal Surgery.

[11]  Chia-Yang Hsu,et al.  Using Serum α-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff? , 2015, PloS one.

[12]  Hyun Jong Kim,et al.  Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  T. Hibi,et al.  Validation of Hepatectomy for Elderly Patients with Hepatocellular Carcinoma , 2015, Annals of Surgical Oncology.

[14]  H. Nakahara,et al.  Safety of hepatectomy for elderly patients with hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[15]  W. Wentao,et al.  Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma , 2014, Medicine.

[16]  Lequn Li,et al.  Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma , 2014, Annals of surgery.

[17]  Yanming Zhou,et al.  Hepatectomy in Elderly Patients: Does Age Matter? , 2013, World Journal of Surgery.

[18]  T. Chua,et al.  Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma - a systematic review. , 2013, Surgical oncology.

[19]  J. Madariaga,et al.  Hepatic resection for hepatocellular carcinoma exceeding Milan criteria. , 2010, Surgical oncology.

[20]  R. Lencioni,et al.  The etiology of hepatocellular carcinoma and consequences for treatment. , 2010, The oncologist.

[21]  S. Kawasaki,et al.  Effects of intermittent Pringle's manoeuvre on cirrhotic compared with normal liver , 2010, The British journal of surgery.

[22]  T. Utsunomiya,et al.  Outcome of repeat hepatectomy in patients with hepatocellular carcinoma aged 75 years and older. , 2010, Surgery.

[23]  D. Chan,et al.  Comparing Hepatic Resection and Transarterial Chemoembolization for Barcelona Clinic Liver Cancer (BCLC) Stage B Hepatocellular Carcinoma: Change for Treatment of Choice? , 2010, World Journal of Surgery.

[24]  J. Bruix,et al.  Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.

[25]  G. Antoch,et al.  Liver Transplantation, Liver Resection, and Transarterial Chemoembolization for Hepatocellular Carcinoma in Cirrhosis: Which Is the Best Oncological Approach? , 2009, Digestive Diseases and Sciences.

[26]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[27]  Guihua Chen,et al.  Long-term Outcomes and Prognostic Factors of Elderly Patients with Hepatocellular Carcinoma Undergoing Hepatectomy , 2009, Journal of Gastrointestinal Surgery.

[28]  Ching-Yu Chen,et al.  Age-period-cohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976-2005. , 2009, Annals of epidemiology.

[29]  Fan Wu,et al.  Solitary Large Hepatocellular Carcinoma: A Specific Subtype of Hepatocellular Carcinoma With Good Outcome After Hepatic Resection , 2009, Annals of surgery.

[30]  J. Marrero,et al.  Diagnosis and treatment of hepatocellular carcinoma. , 2008, Gastroenterology.

[31]  Sheng-Nan Lu,et al.  The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients. , 2008, European journal of cancer.

[32]  K. Menon,et al.  Outcomes after major hepatectomy in elderly patients. , 2006, Journal of the American College of Surgeons.

[33]  X-p Chen,et al.  Long‐term outcome of resection of large hepatocellular carcinoma , 2006, The British journal of surgery.

[34]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[35]  J. Marrero,et al.  Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort , 2005, Hepatology.

[36]  M. Makuuchi,et al.  Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. , 2005, Journal of hepato-biliary-pancreatic surgery.

[37]  H. Sameshima,et al.  Estimation of physiologic ability and surgical stress (E-PASS) for a surgical audit in elective digestive surgery. , 2004, Surgery.

[38]  L. Qin,et al.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma. , 2002, World journal of gastroenterology.

[39]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[40]  A. Venook,et al.  Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.

[41]  S. Kahlert,et al.  Dose-dense and sequential strategies in adjuvant breast cancer therapy. , 2001, Oncology.

[42]  K. Hanazaki,et al.  Hepatic resection for large hepatocellular carcinoma. , 2001, American journal of surgery.

[43]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[44]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[45]  T E Starzl,et al.  Liver transplantation. , 1967, Bulletin de la Societe internationale de chirurgie.